Abstract
We have not added the abstract for this paper yet. The publisher's page has the full record.
Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
The Lancet · Vol. 399, pp. 1049-1058 Published January 1, 2022